We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Biopharmaceutical Buffers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025




 

With the slowdown in world economic growth, the Biopharmaceutical Buffers industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Biopharmaceutical Buffers market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Biopharmaceutical Buffers market size will be further expanded, we expect that by 2023, The market size of the Biopharmaceutical Buffers will reach XXX million $.

A buffer solution contains a weak conjugate acid-base pair. It may contain a weak acid and its conjugate base or a weak base and its conjugate acid. Biopharmaceutical buffers find application in protein-based drugs as many proteins are highly sensitive to pH and other environmental factors. Addition of buffers aids to limit changes in pH.

Increasing development of biopharmaceuticals is expected to propel growth of the global biopharmaceutical buffers market over the forecast period. For instance, according to Pharmaceutical Research and Manufacturers of America, over 750 orphan drugs were approved in the U.S. in 2018, compared to over 600 in 2017.

The market is witnessing increasing approval and launch of biopharmaceuticals, which is boosting growth of the market. For instance, in August 2018, the U.S. Food and Drug Administration approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

Increasing prevalence of chronic disorders is expected to offer lucrative growth opportunities for players in the global biopharmaceutical buffers market. For instance, according to the study, “Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017”, published in the journal Annals of the Rheumatic Diseases, in November 2019, the age-standardized point prevalence and annual incidence rates of rheumatoid arthritis were 246.6 and 14.9 in 2017, which increased by 7.4% and 8.2% from 1990, respectively.  

However, use of buffers presents complexities in manufacturing of biopharmaceutical drugs, which is expected to hinder growth of the global biopharmaceutical buffers market. Buffer solutions used in biopharmaceutical manufacturing are very dilute and require large storage facilities, which increases labor cost and required space.

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in April 2019, MilliporeSigma launched its BioContinuum Buffer Delivery Platform, a new building block in the BioContinuum Platform for next-generation bioprocessing, at INTERPHEX in New York City, U.S.

Key Takeaways

Increasing development of biopharmaceuticals to augment growth of the global biopharmaceutical buffers market over the forecast period

Major players in the market are focused on adopting collaboration strategies to enhance their market share. For instance, in November 2019, Avantor, Inc. collaborated with National Institute for Bioprocessing Research and Training, Ireland, to address downstream issues with buffer preparation when producing monoclonal antibodies.

Major players operating in the global biopharmaceutical buffers market include, GE Healthcare, Thermo Fisher Scientific, Avantor, Inc., Danaher Corporation, Sartorius StedimBiotech, MilliporeSigma (Merck KGaA), Eppendorf, Roche, Nova Biomedicals, Lonza, Becton, and Dickinson and Company, and GEA

This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

Section 1: Definition

Section (2 3): Manufacturer Detail
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA

Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): 
Product Type Segmentation
Sterile Buffer
Non-sterile Buffer

Industry Segmentation
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics

Channel (Direct Sales, Distributor) Segmentation

Section 8: Trend (2018-2023)

Section 9: Product Type Detail

Section 10: Downstream Consumer

Section 11: Cost Structure

Section 12: Conclusion

Table of Contents

Section 1 Biopharmaceutical Buffers Product Definition

Section 2 Global Biopharmaceutical Buffers Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Biopharmaceutical Buffers Shipments
2.2 Global Manufacturer Biopharmaceutical Buffers Business Revenue
2.3 Global Biopharmaceutical Buffers Market Overview

Section 3 Manufacturer Biopharmaceutical Buffers Business Introduction
3.1 GE Healthcare Biopharmaceutical Buffers Business Introduction
3.1.1 GE Healthcare Biopharmaceutical Buffers Shipments, Price, Revenue and Gross profit 2014-2018
3.1.2 GE Healthcare Biopharmaceutical Buffers Business Distribution by Region
3.1.3 GE Healthcare Interview Record
3.1.4 GE Healthcare Biopharmaceutical Buffers Business Profile
3.1.5 GE Healthcare Biopharmaceutical Buffers Product Specification

3.2 Thermo Fisher Scientific Biopharmaceutical Buffers Business Introduction
3.2.1 Thermo Fisher Scientific Biopharmaceutical Buffers Shipments, Price, Revenue and Gross profit 2014-2018
3.2.2 Thermo Fisher Scientific Biopharmaceutical Buffers Business Distribution by Region
3.2.3 Interview Record
3.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Business Overview
3.2.5 Thermo Fisher Scientific Biopharmaceutical Buffers Product Specification

3.3 Danaher Corporation Biopharmaceutical Buffers Business Introduction
3.3.1 Danaher Corporation Biopharmaceutical Buffers Shipments, Price, Revenue and Gross profit 2014-2018
3.3.2 Danaher Corporation Biopharmaceutical Buffers Business Distribution by Region
3.3.3 Interview Record
3.3.4 Danaher Corporation Biopharmaceutical Buffers Business Overview
3.3.5 Danaher Corporation Biopharmaceutical Buffers Product Specification

3.4 Sartorius StedimBiotech Biopharmaceutical Buffers Business Introduction
3.5 Merck Biopharmaceutical Buffers Business Introduction
3.6 Eppendorf Biopharmaceutical Buffers Business Introduction


Section 4 Global Biopharmaceutical Buffers Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.1.2 Canada Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.2 South America Country
4.2.1 South America Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.3 Asia Country
4.3.1 China Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.3.2 Japan Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.3.3 India Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.3.4 Korea Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.4 Europe Country
4.4.1 Germany Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.4.2 UK Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.4.3 France Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.4.4 Italy Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.4.5 Europe Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.5 Other Country and Region
4.5.1 Middle East Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.5.2 Africa Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.5.3 GCC Biopharmaceutical Buffers Market Size and Price Analysis 2014-2018
4.6 Global Biopharmaceutical Buffers Market Segmentation (Region Level) Analysis 2014-2018
4.7 Global Biopharmaceutical Buffers Market Segmentation (Region Level) Analysis

Section 5 Global Biopharmaceutical Buffers Market Segmentation (Product Type Level)
5.1 Global Biopharmaceutical Buffers Market Segmentation (Product Type Level) Market Size 2014-2018
5.2 Different Biopharmaceutical Buffers Product Type Price 2014-2018
5.3 Global Biopharmaceutical Buffers Market Segmentation (Product Type Level) Analysis

Section 6 Global Biopharmaceutical Buffers Market Segmentation (Industry Level)
6.1 Global Biopharmaceutical Buffers Market Segmentation (Industry Level) Market Size 2014-2018
6.2 Different Industry Price 2014-2018
6.3 Global Biopharmaceutical Buffers Market Segmentation (Industry Level) Analysis

Section 7 Global Biopharmaceutical Buffers Market Segmentation (Channel Level)
7.1 Global Biopharmaceutical Buffers Market Segmentation (Channel Level) Sales Volume and Share 2014-2018
7.2 Global Biopharmaceutical Buffers Market Segmentation (Channel Level) Analysis

Section 8 Biopharmaceutical Buffers Market Forecast 2018-2023
8.1 Biopharmaceutical Buffers Segmentation Market Forecast (Region Level)
8.2 Biopharmaceutical Buffers Segmentation Market Forecast (Product Type Level)
8.3 Biopharmaceutical Buffers Segmentation Market Forecast (Industry Level)
8.4 Biopharmaceutical Buffers Segmentation Market Forecast (Channel Level)

Section 9 Biopharmaceutical Buffers Segmentation Product Type
9.1 Sterile Buffer Product Introduction
9.2 Non-sterile Buffer Product Introduction

Section 10 Biopharmaceutical Buffers Segmentation Industry
10.1 Recombinant Proteins Clients
10.2 Monoclonal Antibodies Clients
10.3 Antibiotics Clients
10.4 Probiotics Clients

Section 11 Biopharmaceutical Buffers Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Biopharmaceutical Buffers Product Picture from GE Healthcare
Chart 2014-2018 Global Manufacturer Biopharmaceutical Buffers Shipments (Units)
Chart 2014-2018 Global Manufacturer Biopharmaceutical Buffers Shipments Share
Chart 2014-2018 Global Manufacturer Biopharmaceutical Buffers Business Revenue (Million USD)
Chart 2014-2018 Global Manufacturer Biopharmaceutical Buffers Business Revenue Share
Chart GE Healthcare Biopharmaceutical Buffers Shipments, Price, Revenue and Gross profit 2014-2018
Chart GE Healthcare Biopharmaceutical Buffers Business Distribution
Chart GE Healthcare Interview Record (Partly)
Figure GE Healthcare Biopharmaceutical Buffers Product Picture
Chart GE Healthcare Biopharmaceutical Buffers Business Profile
Table GE Healthcare Biopharmaceutical Buffers Product Specification
Chart Thermo Fisher Scientific Biopharmaceutical Buffers Shipments, Price, Revenue and Gross profit 2014-2018
Chart Thermo Fisher Scientific Biopharmaceutical Buffers Business Distribution
Chart Thermo Fisher Scientific Interview Record (Partly)
Figure Thermo Fisher Scientific Biopharmaceutical Buffers Product Picture
Chart Thermo Fisher Scientific Biopharmaceutical Buffers Business Overview
Table Thermo Fisher Scientific Biopharmaceutical Buffers Product Specification
Chart Danaher Corporation Biopharmaceutical Buffers Shipments, Price, Revenue and Gross profit 2014-2018
Chart Danaher Corporation Biopharmaceutical Buffers Business Distribution
Chart Danaher Corporation Interview Record (Partly)
Figure Danaher Corporation Biopharmaceutical Buffers Product Picture
Chart Danaher Corporation Biopharmaceutical Buffers Business Overview
Table Danaher Corporation Biopharmaceutical Buffers Product Specification
3.4 Sartorius StedimBiotech Biopharmaceutical Buffers Business Introduction

Chart United States Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart United States Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Canada Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Canada Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart South America Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart South America Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart China Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart China Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Japan Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Japan Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart India Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart India Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Korea Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Korea Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Germany Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Germany Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart UK Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart UK Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart France Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart France Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Italy Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Italy Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Europe Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Europe Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Middle East Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Middle East Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Africa Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Africa Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart GCC Biopharmaceutical Buffers Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart GCC Biopharmaceutical Buffers Sales Price ($/Unit) 2014-2018
Chart Global Biopharmaceutical Buffers Market Segmentation (Region Level) Sales Volume 2014-2018
Chart Global Biopharmaceutical Buffers Market Segmentation (Region Level) Market size 2014-2018
Chart Biopharmaceutical Buffers Market Segmentation (Product Type Level) Volume (Units) 2014-2018
Chart Biopharmaceutical Buffers Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018
Chart Different Biopharmaceutical Buffers Product Type Price ($/Unit) 2014-2018
Chart Biopharmaceutical Buffers Market Segmentation (Industry Level) Market Size (Volume) 2014-2018
Chart Biopharmaceutical Buffers Market Segmentation (Industry Level) Market Size (Share) 2014-2018
Chart Biopharmaceutical Buffers Market Segmentation (Industry Level) Market Size (Value) 2014-2018
Chart Global Biopharmaceutical Buffers Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018
Chart Global Biopharmaceutical Buffers Market Segmentation (Channel Level) Share 2014-2018
Chart Biopharmaceutical Buffers Segmentation Market Forecast (Region Level) 2018-2023
Chart Biopharmaceutical Buffers Segmentation Market Forecast (Product Type Level) 2018-2023
Chart Biopharmaceutical Buffers Segmentation Market Forecast (Industry Level) 2018-2023
Chart Biopharmaceutical Buffers Segmentation Market Forecast (Channel Level) 2018-2023
Chart Sterile Buffer Product Figure
Chart Sterile Buffer Product Advantage and Disadvantage Comparison
Chart Non-sterile Buffer Product Figure
Chart Non-sterile Buffer Product Advantage and Disadvantage Comparison
Chart Recombinant Proteins Clients
Chart Monoclonal Antibodies Clients
Chart Antibiotics Clients
Chart Probiotics Clients

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.